Article
Version 1
This version is not peer-reviewed
Anti-Obesity Medication and Household Food Waste
and
*
Version 1
: Received: 28 August 2024 / Approved: 28 August 2024 / Online: 28 August 2024 (20:20:28 CEST)
How to cite: Mansouri, J.; Roe, B. E. Anti-Obesity Medication and Household Food Waste. Preprints 2024, 2024082067. https://doi.org/10.20944/preprints202408.2067.v1 Mansouri, J.; Roe, B. E. Anti-Obesity Medication and Household Food Waste. Preprints 2024, 2024082067. https://doi.org/10.20944/preprints202408.2067.v1
Abstract
Glucagon-like peptide-1 (GLP-1) agonists are gaining attention as a potential treatment for obesity. While studies have shown that these medications greatly impact dietary habits, their relationship to consumer food waste is unexplored. We analyzed data from 505 U.S. consumers who self-report GLP-1 medication use and found that 25% agree that they waste more food since beginning the medication with 61% disagreeing with this statement. Respondents are less likely to agree with this statement if they have been on the medication a longer time and more likely to agree if they report experiencing nausea since beginning the medication. Several dietary changes are also significantly associated with self-reported changes in food waste since starting the medication. With previous literature finding GLP-1’s significant impact on individual food consumption and dietary choices, our findings suggest that the effects of this novel class of anti-obesity medications may cast a significant impact on food waste patterns. With the potential for widespread adoption of these medications, and given that approximately one-third of food in the United States is wasted by consumers, understanding the interaction of these two consumer trends is critical for projecting their joint impact on the food system.
Keywords
food waste; anti-obesity medications; Glucagon-like peptide-1 agonist; U.S. consumers; survey
Subject
Business, Economics and Management, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
